89 related articles for article (PubMed ID: 29927730)
1. The relationship between gene polymorphism of MTRR A66G and lower extremity deep venous thrombosis.
Xu J; Zhou W
Hematology; 2018 Dec; 23(10):828-832. PubMed ID: 29927730
[TBL] [Abstract][Full Text] [Related]
2. Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians.
Naushad SM; Jain Jamal MN; Prasad CK; Rama Devi AR
Clin Chem Lab Med; 2008; 46(1):73-9. PubMed ID: 18034637
[TBL] [Abstract][Full Text] [Related]
3. [Association of methionine synthase reductase gene polymorphism with unexplained recurrent spontaneous abortion].
Guo QN; Liao SX; Kang B; Zhang JX; Wang RL; Ding XB; Zhang WH
Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):742-6. PubMed ID: 23302731
[TBL] [Abstract][Full Text] [Related]
4. Relationship between genetic polymorphism of MTHFR C677T and lower extremities deep venous thrombosis.
Xu J; Li K; Zhou W
Hematology; 2019 Dec; 24(1):108-111. PubMed ID: 30303041
[TBL] [Abstract][Full Text] [Related]
5. Associations of MTHFR C677T and MTRR A66G gene polymorphisms with metabolic syndrome: a case-control study in Northern China.
Yang B; Fan S; Zhi X; Wang D; Li Y; Wang Y; Wang Y; Wei J; Zheng Q; Sun G
Int J Mol Sci; 2014 Nov; 15(12):21687-702. PubMed ID: 25429430
[TBL] [Abstract][Full Text] [Related]
6. Methionine Synthase Reductase-A66G and -C524T Single Nucleotide Polymorphisms and Prostate Cancer: A Case-Control Trial.
Basir A
Asian Pac J Cancer Prev; 2019 May; 20(5):1445-1451. PubMed ID: 31127906
[TBL] [Abstract][Full Text] [Related]
7. Methionine synthase reductase A66G polymorphism and leukemia risk: evidence from published studies.
Fang DH; Ji Q; Fan CH; An Q; Li J
Leuk Lymphoma; 2014 Aug; 55(8):1910-4. PubMed ID: 24261678
[TBL] [Abstract][Full Text] [Related]
8. A66G and C524T polymorphisms of methionine synthase reductase gene are linked to the development of acyanotic congenital heart diseases in Egyptian children.
Hassan FM; Khattab AA; Abo El Fotoh WMM; Zidan RS
Gene; 2017 Sep; 629():59-63. PubMed ID: 28778621
[TBL] [Abstract][Full Text] [Related]
9. Methionine synthase reductase A66G polymorphism is not associated with breast cancer susceptibility - a meta-analysis.
Hu S; Liu HC; Xi SM
Asian Pac J Cancer Prev; 2014; 15(7):3267-71. PubMed ID: 24815481
[TBL] [Abstract][Full Text] [Related]
10. MTRR A66G polymorphism among two caste groups of Uttar Pradesh (India).
Rai V; Yadav U; Kumar P
Indian J Med Sci; 2012; 66(5-6):136-40. PubMed ID: 23806987
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms predisposing to hyperhomocysteinemia in cardiac transplant patients.
Miriuka SG; Langman LJ; Evrovski J; Miner SE; D'Mello N; Delgado DH; Wong BY; Ross HJ; Cole DE
Transpl Int; 2005 Jan; 18(1):29-35. PubMed ID: 15612980
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility.
Wu PP; Tang RN; An L
J BUON; 2015; 20(3):918-22. PubMed ID: 26214647
[TBL] [Abstract][Full Text] [Related]
13. Methionine synthase reductase (MTRR) A66G polymorphism is not related to plasma homocysteine concentration and the risk for vascular disease.
Scazzone C; Acuto S; Guglielmini E; Campisi G; Bono A
Exp Mol Pathol; 2009 Apr; 86(2):131-3. PubMed ID: 19348062
[TBL] [Abstract][Full Text] [Related]
14. Association of Three Single Nucleotide Polymorphisms in MTR and MTRR Genes with Lung Cancer in a Turkish Population.
Aksoy-Sagirli P; Erdenay A; Kaytan-Saglam E; Kizir A
Genet Test Mol Biomarkers; 2017 Jul; 21(7):428-432. PubMed ID: 28537809
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk.
Lima CS; Ortega MM; Ozelo MC; Araujo RC; De Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; Costa FF
Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928
[TBL] [Abstract][Full Text] [Related]
16. Association between methionine synthase reductase A66G polymorphism and the risk of congenital heart defects: evidence from eight case-control studies.
Yu D; Yang L; Shen S; Fan C; Zhang W; Mo X
Pediatr Cardiol; 2014 Oct; 35(7):1091-8. PubMed ID: 24913415
[TBL] [Abstract][Full Text] [Related]
17. Analysis of methionine synthase reductase polymorphism (A66G) in Indian Muslim population.
Rai V; Yadav U; Kumar P; Yadav SK
Indian J Hum Genet; 2013 Apr; 19(2):183-7. PubMed ID: 24019620
[TBL] [Abstract][Full Text] [Related]
18. A polymorphism of the methionine synthase reductase gene increases chromosomal damage in peripheral lymphocytes in smokers.
Ishikawa H; Ishikawa T; Miyatsu Y; Kurihara K; Fukao A; Yokoyama K
Mutat Res; 2006 Jul; 599(1-2):135-43. PubMed ID: 16580699
[TBL] [Abstract][Full Text] [Related]
19. Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease.
Laraqui A; Allami A; Carrié A; Coiffard AS; Benkouka F; Benjouad A; Bendriss A; Kadiri N; Bennouar N; Benomar A; Guedira A; Raisonnier A; Fellati S; Srairi JE; Benomar M
Acta Cardiol; 2006 Feb; 61(1):51-61. PubMed ID: 16485733
[TBL] [Abstract][Full Text] [Related]
20. Association between MTR A2756G and MTRR A66G polymorphisms and maternal risk for neural tube defects: a meta-analysis.
Ouyang S; Li Y; Liu Z; Chang H; Wu J
Gene; 2013 Feb; 515(2):308-12. PubMed ID: 23266814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
